DiaSorin gets EUA for Liaison SARS-CoV-2 Ag
April 1, 2021—DiaSorin received emergency use authorization from the FDA for its Liaison SARS-CoV-2 Ag.
Webinars and Sponsored Roundtables — Register Now
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Qiagen gets EUA for NeuMoDx COVID-19 multiplex test
March 31, 2021— Qiagen announced FDA emergency use authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay, to help identify people suspected of respiratory viral infection consistent with COVID-19.
FDA authorizes Quidel QuickVue At-Home COVID-19 test
March 30, 2021—The FDA issued an emergency use authorization for the Quidel QuickVue At-Home COVID-19 test.
Agena launches panel for SARS-CoV-2 variants
March 29, 2021—Agena Bioscience launched its MassArray SARS-CoV-2 Variant Panel (RUO) for the detection of key SARS-CoV-2 virus strains.
Diazyme semiquantitative SARS-CoV-2 IgG test gets EUA
March 26, 2021—Diazyme received FDA emergency use authorization for its Semi-Quantitative DZ-Lite SARS-CoV-2 IgG CLIA test, which runs on the DZ-Lite 3000 Plus chemiluminescence analyzer.
Roche launches SARS-CoV-2 variant test
March 25, 2021—Roche launched the Cobas SARS-CoV-2 Variant Set 1 Test to detect and differentiate mutations found in variants that originated in the U.K. (B.1.1.7), South Africa (B.1.351), and Brazil (P.1).
Thermo Fisher’s customizable SARS-CoV-2 mutation panel
March 24, 2021—Thermo Fisher Scientific launched its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a customizable menu of 22 verified real-time PCR assays for identification of SARS-CoV-2 mutations.
FDA approves Ventana ALK (D5F3) CDx assay with Lobrena
March 23, 2021—Roche announced FDA approval of the Ventana ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer patients eligible for treatment with Pfizer’s drug Lorbrena (lorlatinib).
QIAsphere cloud-based platform launched with QIAstat-Dx
March 22, 2021—Qiagen launched its QIAsphere cloud-based platform that will allow labs and QIAstat-Dx users to monitor tests and instrument status remotely 24 hours a day, seven days a week.
Bio SB launches antibodies for SARS-CoV-2
March 19, 2021—Bio SB has developed a new panel of SARS-CoV-2 antibodies to identify the COVID-19 virus, its receptors, and cytokines by immunohistochemistry and immunofluorescence on formalin-fixed, paraffin-embedded biopsies.